Market Size of North America Regenerative Medicines Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 19.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Regenerative Medicine Market Analysis
The North America Regenerative Medicine Market is expected to register a CAGR of nearly 19.5 % during the forecast period. The key factors propelling the growth of the North America regenerative medicine market are the increasing adoption of stem cell technologies, gene therapies, and tissue engineering, and the technological advancements in regenerative medicine.
As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030.
Technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. Thus, owing to the above mentioned factors the market is expected to show significant growth over the forecast period.
North America Regenerative Medicine Industry Segmentation
As per the scope of the report, regenerative medicines are used to repair, replace, and regenerate the tissues and organs affected by injury, disease, or the natural ageing process. These medicines restore the functionality of cells and tissues and are used in several degenerative disorders, such as dermatology, neurodegenerative diseases, cardiovascular, and orthopaedic applications. The North America Regenerative Medicine Market is segmented by type of technology application and geography.
| By Type of Technology | |
| Stem Cell Therapy | |
| Biomaterial | |
| Tissue Engineering | |
| Other Types of Technologies |
| By Application | |
| Bone Graft Substitutes | |
| Osteoarticular Diseases | |
| Dermatology | |
| Cardiovascular | |
| Central Nervous System | |
| Other Applications |
| Geography | |||||
|
North America Regenerative Medicines Market Size Summary
The North America regenerative medicine market is poised for substantial growth, driven by the increasing adoption of advanced technologies such as stem cell therapies, gene therapies, and tissue engineering. Technological advancements in biologics and biomaterials are further propelling this expansion. The market is expected to experience significant growth over the forecast period, with the dermatology segment anticipated to lead in revenue generation. This dominance is attributed to the effective grafting techniques available for dermatological applications and the abundant stem cell sources from skin layers, which facilitate a wide range of products for treating injuries and chronic wounds.
The market landscape is highly competitive, with both small and large companies investing heavily in novel technologies to develop tissue models for research and therapeutic applications. The rising incidence of injuries and traffic-related fatalities is also contributing to the market's growth, as these factors increase the demand for regenerative medicine solutions. Companies like Integra Lifesciences, Organogenesis Inc, and Osiris Therapeutics are key players in this space, and the market is expected to see new entrants in the coming years, further intensifying the competition.
North America Regenerative Medicines Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Adoption of Stem Cell Technology
-
1.2.2 Technological Advancements in Regenerative Medicine
-
-
1.3 Market Restraints
-
1.3.1 Regulatory and Ethical Issues
-
1.3.2 High Cost of Treatments
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type of Technology
-
2.1.1 Stem Cell Therapy
-
2.1.2 Biomaterial
-
2.1.3 Tissue Engineering
-
2.1.4 Other Types of Technologies
-
-
2.2 By Application
-
2.2.1 Bone Graft Substitutes
-
2.2.2 Osteoarticular Diseases
-
2.2.3 Dermatology
-
2.2.4 Cardiovascular
-
2.2.5 Central Nervous System
-
2.2.6 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
-
North America Regenerative Medicines Market Size FAQs
What is the current North America Regenerative Medicines Market size?
The North America Regenerative Medicines Market is projected to register a CAGR of 19.5% during the forecast period (2024-2029)
Who are the key players in North America Regenerative Medicines Market?
Integra Lifesciences, Organogenesis Inc, Osiris Therapeutics (Smith & Nephew), Abbvie Inc (Allergan Plc) and Cook Medical (Cook Biotech Incorporated) are the major companies operating in the North America Regenerative Medicines Market.
